Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compounds D and E in a humanized mouse model of psoriasis
NL-OMON34058Active, not recruiting
- Sponsor
- TNO
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of trifluoperazine and cortisone in psoriasis and plaque psoriasis, sponsored by TNO. Primary endpoints: Effect on the psoriatic process in transplanted biopsies and Epidermal thickness. Started Oct 2010; status: active, not recruiting.
02
Drugs
trifluoperazinecortisone
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on NL-OMON34058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34058.